Reversal Therapeutics is a preclinical biopharmaceutical company developing proprietary sequestration-based molecules that bind harmful agents and enable their removal from the body
Reversal Therapeutics is a preclinical biopharmaceutical company developing proprietary sequestration-based molecules that bind harmful agents and enable their removal from the body. Its lead program aims to reverse neuromuscular blockade caused by major neuromuscular blocking agents, with additional research into drug detoxification.